Octagon Capital Advisors LP - DESIGN THERAPEUTICS INC ownership

DESIGN THERAPEUTICS INC's ticker is DSGN and the CUSIP is 25056L103. A total of 44 filers reported holding DESIGN THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is - and the average weighting 0.4%.

Quarter-by-quarter ownership
Octagon Capital Advisors LP ownership history of DESIGN THERAPEUTICS INC
ValueSharesWeighting
Q3 2021$219,000
-95.6%
14,926
-94.0%
0.05%
-94.8%
Q2 2021$4,973,000
-33.5%
250,0000.0%1.03%
-63.4%
Q1 2021$7,475,000250,0002.82%
Other shareholders
DESIGN THERAPEUTICS INC shareholders Q1 2021
NameSharesValueWeighting ↓
SR ONE CAPITAL MANAGEMENT, LP 5,626,476$78,771,00038.55%
Logos Global Management LP 2,797,501$39,165,0007.18%
Cormorant Asset Management, LP 5,500,000$77,000,0005.82%
Ghost Tree Capital, LLC 275,000$3,850,0002.00%
EcoR1 Capital, LLC 2,634,178$36,878,0001.27%
RA Capital Management 2,186,636$30,613,0000.82%
Vivo Capital, LLC 476,589$6,672,0000.67%
Avoro Capital Advisors LLC 2,222,222$31,111,0000.62%
Artal Group S.A. 400,000$5,600,0000.30%
Rock Springs Capital Management LP 460,391$6,445,0000.19%
View complete list of DESIGN THERAPEUTICS INC shareholders